Evidence map›Paper›PMID 25581412›Full record

ArticleBone marrow transplantation2015

Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

J Harvey, A Green, S J Groves, J Cornish, J Moppett, M Cummins, L Keen, S Culliford, A Poles, W Hulme and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

J HarveyDepartment of Histocompatibility and Immunogenetics, NHS Blood and Transplant, Bristol, UK.
A GreenDepartment of Histocompatibility and Immunogenetics, NHS Blood and Transplant, Bristol, UK.
S J GrovesBone Marrow Transplant Unit, Bristol Royal Hospital for Children, Bristol, UK.
J CornishSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
J MoppettSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.ORCID 0000000318443531
M CumminsSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
L KeenDepartment of Histocompatibility and Immunogenetics, NHS Blood and Transplant, Bristol, UK.
S CullifordDepartment of Histocompatibility and Immunogenetics, NHS Blood and Transplant, Bristol, UK.
A PolesDepartment of Histocompatibility and Immunogenetics, NHS Blood and Transplant, Bristol, UK.
W HulmeStatistics and Clinical Audit, Clinical Directorate, Organ Donor Registry, NHS Blood and Transplant, Bristol, UK.
Y LiBritish Bone Marrow Registry, NHS Blood and Transplant, Bristol, UK.
C G Steward1] Bone Marrow Transplant Unit, Bristol Royal Hospital for Children, Bristol, UK [2] School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
NHS Blood and Transplant · GBUniversity of Bristol · GBBristol Royal Hospital for Children · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microsatellite analyses show that self-reported ethnicity often correlates poorly with true genetic ancestry. As unknown ancestral differences could potentially have an impact on transplant outcome, we developed an average allele length discrepancy (AALD) score to assess allele length discrepancy between donor/recipient (D/R) using microsatellites analysed routinely in post-transplant chimeric assessment. This was then compared with outcome in a homogeneously treated cohort of pediatric patients undergoing high-resolution sibling or matched unrelated donor transplantation for acute lymphoblastic leukemia (ALL). AALD scores formed a numeric continuum ranging from 0 to 1.4 (median 0.76) for sibling pairs and 0.8-2.17 (median 1.6) for high-resolution matched unrelated donor (HR-MUD) pairs. There was a trend for worse OS with increasing AALD score, which reached statistical significance above a threshold of 1.7 for OS. Patients whose transplants had an AALD score of ⩾1.8 had a risk of non-relapse mortality 4.9 times greater (P=0.025) and relapse risk three times greater (P=0.058) than those scoring <1.8. This approach will now be explored in a Centre International for Blood and Marrow Transplantation Research (CIBMTR) study of 750 D/R pairs across all disease groups; if confirmed, it has the potential to improve donor selection for patients with multiple prospective donors.

Indexed as

Microsatellite RepeatsHematopoietic Stem Cell TransplantationHumansPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisTransplantation ConditioningTreatment Outcome

Identifiers

PMID25581412
OpenAlexW1988004706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.